Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maud Michaud

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
BMJ Case Reports|April 12, 2022
Neuromyotonia: a skin-deep problemFrançois Maurier, Maud Michaud, Roxane Reviron, et al.
European Journal of Medical Genetics|July 28, 2025
Further delineation of LRSAM1-related Charcot-Marie-Tooth type 2P with parkinsonismPauline Ducatel, Antoine Verger, Marion Selton, et al.
Journal of Neuromuscular Diseases|June 16, 2020
Ganglionopathies Associated with MERRF Syndrome: An Original ReportMaud Michaud, Tanya Stojkovic, Thierry Maisonobe, et al.
Plos One|March 28, 2018
Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational studyClotilde Nardin, Clotilde Latarche, Marc Soudant, et al.
Journal of the Peripheral Nervous System : JPNS|March 2, 2023
Neurolymphomatosis: involvement of peripheral nervous system revealing hematologic malignancy, a report of nine casesPauline Ducatel, Maud Michaud, Karine Viala, et al.
Parkinsonism & Related Disorders|February 21, 2023
Heterozygous pathogenic variation in GCH1 associated with treatable severe spastic tetraplegiaJean-Marie Ravel, Maud Michaud, Solène Frismand, et al.
Journal of Neurology|July 4, 2020
Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease InactivityAnne-Laure Kaminsky, Abdou Yacoubou Omorou, Marc Soudant, et al.
European Journal of Neurology|December 20, 2021
Motor and respiratory decline in patients with late onset Pompe disease after cessation of enzyme replacement therapy during COVID-19 pandemicCéline Tard, Emmanuelle Salort-Campana, Maud Michaud, et al.
Journal of Neurology|November 11, 2023
Clinical and genetic features of patients suffering from CMT4JSadia Beloribi-Djefaflia, Raul Juntas Morales, Farzad Fatehi, et al.
Archives of Cardiovascular Diseases|February 22, 2026
Impact of RNAi therapeutics on cardiac parameters in patients with hereditary transthyretin amyloidosis initially treated with stabilizers: A French real-world studyAntoine Fraix, Vincent Algalarrondo, Olivier Lairez, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
BMJ Case Reports|April 12, 2022
Neuromyotonia: a skin-deep problemFrançois Maurier, Maud Michaud, Roxane Reviron, et al.
European Journal of Medical Genetics|July 28, 2025
Further delineation of LRSAM1-related Charcot-Marie-Tooth type 2P with parkinsonismPauline Ducatel, Antoine Verger, Marion Selton, et al.
Journal of Neuromuscular Diseases|June 16, 2020
Ganglionopathies Associated with MERRF Syndrome: An Original ReportMaud Michaud, Tanya Stojkovic, Thierry Maisonobe, et al.
Plos One|March 28, 2018
Generational changes in multiple sclerosis phenotype in North African immigrants in France: A population-based observational studyClotilde Nardin, Clotilde Latarche, Marc Soudant, et al.
Journal of the Peripheral Nervous System : JPNS|March 2, 2023
Neurolymphomatosis: involvement of peripheral nervous system revealing hematologic malignancy, a report of nine casesPauline Ducatel, Maud Michaud, Karine Viala, et al.
Parkinsonism & Related Disorders|February 21, 2023
Heterozygous pathogenic variation in GCH1 associated with treatable severe spastic tetraplegiaJean-Marie Ravel, Maud Michaud, Solène Frismand, et al.
Journal of Neurology|July 4, 2020
Discontinuation of disease-modifying treatments for multiple sclerosis in patients aged over 50 with disease InactivityAnne-Laure Kaminsky, Abdou Yacoubou Omorou, Marc Soudant, et al.
European Journal of Neurology|December 20, 2021
Motor and respiratory decline in patients with late onset Pompe disease after cessation of enzyme replacement therapy during COVID-19 pandemicCéline Tard, Emmanuelle Salort-Campana, Maud Michaud, et al.
Journal of Neurology|November 11, 2023
Clinical and genetic features of patients suffering from CMT4JSadia Beloribi-Djefaflia, Raul Juntas Morales, Farzad Fatehi, et al.
Archives of Cardiovascular Diseases|February 22, 2026
Impact of RNAi therapeutics on cardiac parameters in patients with hereditary transthyretin amyloidosis initially treated with stabilizers: A French real-world studyAntoine Fraix, Vincent Algalarrondo, Olivier Lairez, et al.
Pageof 3